Literature DB >> 19650644

Impaired protofibril formation in fibrinogen gamma N308K is due to altered D:D and "A:a" interactions.

Sheryl R Bowley1, Nobuo Okumura, Susan T Lord.   

Abstract

"A:a" knob-hole interactions and D:D interfacial interactions are important for fibrin polymerization. Previous studies with recombinant gammaN308K fibrinogen, a substitution at the D:D interface, showed impaired polymerization. We examined the molecular basis for this loss of function by solving the crystal structure of gammaN308K fragment D. In contrast to previous fragment D crystals, the gammaN308K crystals belonged to a tetragonal space group with an unusually long unit cell (a = b = 95 A, c = 448.3 A). Alignment of the normal and gammaN308K structures showed the global structure of the variant was not changed and the knob "A" peptide GPRP was bound as usual to hole "a". The substitution introduced an elongated positively charged patch in the D:D region. The structure showed novel, symmetric D:D crystal contacts between gammaN308K molecules, indicating the normal asymmetric D:D interface in fibrin would be unstable in this variant. We examined GPRP binding to gammaN308K in solution by plasmin protection assay. The results showed weaker peptide binding, suggesting that "A:a" interactions were altered. We examined fibrin network structures by scanning electron microscopy and found the variant fibers were thicker and more heterogeneous than normal fibers. Considered together, our structural and biochemical studies indicate both "A:a" and D:D interactions are weaker. We conclude that stable protofibrils cannot assemble from gammaN308K monomers, leading to impaired polymerization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650644      PMCID: PMC2956063          DOI: 10.1021/bi900239b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.

Authors:  Z Yang; I Mochalkin; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D.

Authors:  F Haverkate; G Timan
Journal:  Thromb Res       Date:  1977-06       Impact factor: 3.944

3.  The synthetic peptide Gly-Pro-Arg-Pro-amide limits the plasmic digestion of fibrinogen in the same fashion as calcium ion.

Authors:  K Yamazumi; R F Doolittle
Journal:  Protein Sci       Date:  1992-12       Impact factor: 6.725

Review 4.  Protein-protein crystal-packing contacts.

Authors:  O Carugo; P Argos
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

5.  A lower molecular weight gamma-chain variant in a congenital abnormal fibrinogen (Kyoto).

Authors:  N Yoshida; M Okuma; M Moroi; M Matsuda
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.

Authors:  G Spraggon; S J Everse; R F Doolittle
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

8.  2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site.

Authors:  Michael S Kostelansky; Laurie Betts; Oleg V Gorkun; Susan T Lord
Journal:  Biochemistry       Date:  2002-10-08       Impact factor: 3.162

9.  Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.

Authors:  N Yoshida; S Terukina; M Okuma; M Moroi; N Aoki; M Matsuda
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  6 in total

Review 1.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

2.  Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation and mass spectrometry.

Authors:  Vitaliy Ovod; Evan A Scott; Megan M Flake; Stanley R Parker; Randall J Bateman; Donald L Elbert
Journal:  J Biomed Mater Res A       Date:  2011-12-30       Impact factor: 4.396

Review 3.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 4.  The molecular origins of the mechanical properties of fibrin.

Authors:  Michael R Falvo; Oleg V Gorkun; Susan T Lord
Journal:  Biophys Chem       Date:  2010-11       Impact factor: 2.352

5.  Development of Transient Recombinant Expression and Affinity Chromatography Systems for Human Fibrinogen.

Authors:  Grega Popovic; Nicholas C Kirby; Taylor C Dement; Kristine M Peterson; Caroline E Daub; Heather A Belcher; Martin Guthold; Adam R Offenbacher; Nathan E Hudson
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 6.208

6.  Does topology drive fiber polymerization?

Authors:  Lihong Huang; Joe Ping-Lin Hsiao; Camilla Powierza; Russell M Taylor; Susan T Lord
Journal:  Biochemistry       Date:  2014-12-05       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.